Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
29 Oct 2024 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2023
|
|
|
29 Oct 2024 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
|
|
|
29 Oct 2024 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
|
|
|
29 Oct 2024 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/23
|
|
|
15 Jul 2024 |
CS01 |
Confirmation statement made on 11 July 2024 with no updates
|
|
|
05 Apr 2024 |
MR01 |
Registration of charge 092346640002, created on 2 April 2024
|
|
|
05 Apr 2024 |
MR01 |
Registration of charge 092346640003, created on 2 April 2024
|
|
|
21 Dec 2023 |
MR04 |
Satisfaction of charge 092346640001 in full
|
|
|
27 Oct 2023 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2022
|
|
|
27 Oct 2023 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/22
|
|
|
27 Oct 2023 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/22
|
|
|
27 Oct 2023 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/22
|
|
|
12 Jul 2023 |
CS01 |
Confirmation statement made on 11 July 2023 with updates
|
|
|
13 Jul 2022 |
AA |
Total exemption full accounts made up to 31 December 2021
|
|
|
11 Jul 2022 |
CS01 |
Confirmation statement made on 11 July 2022 with updates
|
|
|
11 Feb 2022 |
CERTNM |
Company name changed seps pharma LIMITED\certificate issued on 11/02/22
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2022-02-09
|
|
|
09 Feb 2022 |
AP01 |
Appointment of Mr Samie Aldoori as a director on 9 February 2022
|
|
|
03 Feb 2022 |
MR01 |
Registration of charge 092346640001, created on 1 February 2022
|
|
|
01 Feb 2022 |
PSC07 |
Cessation of Mohammed Khalid Aldoori as a person with significant control on 31 January 2022
|
|
|
01 Feb 2022 |
PSC02 |
Notification of Crescent Pharmaceuticals Limited as a person with significant control on 31 January 2022
|
|
|
12 Jan 2022 |
CS01 |
Confirmation statement made on 1 January 2022 with no updates
|
|
|
29 Sep 2021 |
AA |
Total exemption full accounts made up to 31 December 2020
|
|
|
29 Sep 2021 |
CS01 |
Confirmation statement made on 29 September 2021 with updates
|
|
|
07 Jan 2021 |
CS01 |
Confirmation statement made on 1 January 2021 with no updates
|
|
|
10 Jul 2020 |
AA |
Total exemption full accounts made up to 31 December 2019
|
|